{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:55:33Z","timestamp":1790999733947,"version":"4.1.0"},"reference-count":25,"publisher":"Japanese Circulation Society","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2026,10,3]]},"DOI":"10.1253\/circj.cj-26-0697","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:11:33Z","timestamp":1790979093000},"source":"Crossref","is-referenced-by-count":0,"title":["In-Hospital Guideline-Directed Medical Therapy Intensification and Long-Term Outcomes in Patients Hospitalized for Heart Failure in the Current Clinical Paradigm\u3000\u2015 Insights From the QHEART-R Study \u2015"],"prefix":"10.1253","author":[{"given":"Toru","family":"Hashimoto","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuichi","family":"Matsukawa","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University"},{"name":"Department of Cardiovascular Medicine, Aso Iizuka Hospital"},{"name":"Department of Cardiovascular Medicine, Fukuoka Red Cross Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouji","family":"Matsushima","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayo","family":"Misumi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeo","family":"Fujino","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Shinohara","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Fujiwara","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, JCHO Kyushu Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Umemoto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, JCHO Kyushu Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Furusawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Saiseikai Futsukaichi Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihito","family":"Ishikita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Saiseikai Fukuoka General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosei","family":"Ishimaru","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Aso Iizuka Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kisanuki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University"},{"name":"Department of Cardiovascular Medicine, Fukuoka Red Cross Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Tokumoto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University"},{"name":"Department of Cardiovascular Medicine, Fukuoka Red Cross Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Yoshitake","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Ikuta","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gentaro","family":"Taniguchi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohtaro","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the QHEART-R Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Groenewegen A, Rutten FH, Mosterd A, Hoes AW. Epidemiology of heart failure. <i>Eur J Heart Fail<\/i> 2020; 22: 1342\u20131356, doi:10.1002\/ejhf.1858.","DOI":"10.1002\/ejhf.1858"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Fujimoto Y, Kitai T, Horiuchi Y, Kondo T, Murai R, Matsukawa R, et al. Contemporary guideline-directed medical therapy and outpatient worsening heart failure events in hospitalized patients with heart failure: Preliminary Observational Study on Utilizing Predischarge Period for Optimizing Medications in Hospitalized Patients With Heart Failure (PRE-UPFRONT-HF). <i>Circ J<\/i> 2025; 89: 912\u2013920, doi:10.1253\/circj.CJ-24-1020.","DOI":"10.1253\/circj.CJ-24-1020"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Shiraishi Y, Kohsaka S, Sato N, Takano T, Kitai T, Yoshikawa T, et al. 9-Year trend in the management of acute heart failure in Japan: A report from the national consortium of acute heart failure registries. <i>J Am Heart Assoc<\/i> 2018; 7: e008687, doi:10.1161\/JAHA.118.008687.","DOI":"10.1161\/JAHA.118.008687"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Ide T, Kaku H, Matsushima S, Tohyama T, Enzan N, Funakoshi K, et al. Clinical characteristics and outcomes of hospitalized patients with heart failure from the large-scale Japanese Registry Of Acute Decompensated Heart Failure (JROADHF). <i>Circ J<\/i> 2021; 85: 1438\u20131450, doi:10.1253\/circj.CJ-20-0947.","DOI":"10.1253\/circj.CJ-20-0947"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Mebazaa A, Davison B, Chioncel O, Cohen-Solal A, Diaz R, Filippatos G, et al. Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): A multinational, open-label, randomised, trial. <i>Lancet<\/i> 2022; 400: 1938\u20131952, doi:10.1016\/S0140-6736(22)02076-1.","DOI":"10.1016\/S0140-6736(22)02076-1"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Matsukawa R, Okahara A, Tokutome M, Itonaga J, Koga E, Hara A, et al. A scoring evaluation for the practical introduction of guideline-directed medical therapy in heart failure patients. <i>ESC Heart Fail<\/i> 2023; 10: 3352\u20133363, doi:10.1002\/ehf2.14524.","DOI":"10.1002\/ehf2.14524"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Greene SJ, Ayodele I, Pierce JB, Khan MS, Lewsey SC, Yancy CW, et al. Eligibility and projected benefits of rapid initiation of quadruple therapy for newly diagnosed heart failure. <i>JACC Heart Fail<\/i> 2024; 12: 1365\u20131377, doi:10.1016\/j.jchf.2024.03.001.","DOI":"10.1016\/j.jchf.2024.03.001"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Jacobs JA, Ayodele I, Bress AP, Sterling MR, Pandey A, Derington CG, et al. Social determinants of health and disparities in guideline-directed medical therapy optimization for heart failure. <i>Circ Heart Fail<\/i> 2025; 18: e012357, doi:10.1161\/CIRCHEARTFAILURE.124.012357.","DOI":"10.1161\/CIRCHEARTFAILURE.124.012357"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Matsukawa R, Kabu K, Koga E, Hara A, Kisanuki H, Sada M, et al. Optimizing guideline-directed medical therapy during hospitalization improves prognosis in patients with worsening heart failure requiring readmissions. <i>Circ J<\/i> 2024; 88: 1416\u20131424, doi:10.1253\/circj.CJ-24-0265.","DOI":"10.1253\/circj.CJ-24-0265"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Authors\/Task Force Members, McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. <i>Eur J Heart Fail<\/i> 2022; 24: 4\u2013131, doi:10.1002\/ejhf.2333.","DOI":"10.1002\/ejhf.2333"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Tsutsui H, Ide T, Ito H, Kihara Y, Kinugawa K, Kinugawa S, et al. JCS\/JHFS 2021 Guideline focused update on diagnosis and treatment of acute and chronic heart failure. <i>Circ J<\/i> 2021; 85: 2252\u20132291, doi:10.1253\/circj.CJ-21-0431.","DOI":"10.1253\/circj.CJ-21-0431"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Malgie J, Wilde MI, Brunner-La Rocca HP, Emans ME, De Boer GA, Siegers CEP, et al. Newly diagnosed heart failure with reduced ejection fraction: Timing, sequencing, and titration of guideline-recommended medical therapy. <i>Eur Heart J<\/i> 2025; 46: 2394\u20132405, doi:10.1093\/eurheartj\/ehaf244.","DOI":"10.1093\/eurheartj\/ehaf244"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Sundaram V, Nagai T, Chiang CE, Reddy YNV, Chao TF, Zakeri R, et al. Hospitalization for heart failure in the United States, UK, Taiwan, and Japan: An international comparison of administrative health records on 413,385 individual patients. <i>J Card Fail<\/i> 2022; 28: 353\u2013366, doi:10.1016\/j.cardfail.2021.08.024.","DOI":"10.1016\/j.cardfail.2021.08.024"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Bates BA, Enzan N, Tohyama T, Gandhi P, Matsushima S, Tsutsui H, et al. Management and outcomes of heart failure hospitalization among older adults in the United States and Japan. <i>ESC Heart Fail<\/i> 2024; 11: 3395\u20133405, doi:10.1002\/ehf2.14873.","DOI":"10.1002\/ehf2.14873"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Packer M, Fowler MB, Roecker EB, Coats AJ, Katus HA, Krum H, et al. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: Results of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study. <i>Circulation<\/i> 2002; 106: 2194\u20132199, doi:10.1161\/01.cir.0000035653.72855.bf.","DOI":"10.1161\/01.CIR.0000035653.72855.BF"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, et al. Angiotensin\u2013neprilysin inhibition versus enalapril in heart failure. <i>N Engl J Med<\/i> 2014; 371: 993\u20131004, doi:10.1056\/NEJMoa1409077.","DOI":"10.1056\/NEJMoa1409077"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, et al. Eplerenone in patients with systolic heart failure and mild symptoms. <i>N Engl J Med<\/i> 2011; 364: 11\u201321, doi:10.1056\/NEJMoa1009492.","DOI":"10.1056\/NEJMoa1009492"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P, et al. Cardiovascular and renal outcomes with empagliflozin in heart failure. <i>N Engl J Med<\/i> 2020; 383: 1413\u20131424, doi:10.1056\/NEJMoa2022190.","DOI":"10.1056\/NEJMoa2022190"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Anker SD, Butler J, Filippatos G, Ferreira JP, Bocchi E, Bohm M, et al. Empagliflozin in heart failure with a preserved ejection fraction. <i>N Engl J Med<\/i> 2021; 385: 1451\u20131461, doi:10.1056\/NEJMoa2107038.","DOI":"10.1056\/NEJMoa2107038"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Solomon SD, McMurray JJV, Claggett B, de Boer RA, DeMets D, Hernandez AF, et al. Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction. <i>N Engl J Med<\/i> 2022; 387: 1089\u20131098, doi:10.1056\/NEJMoa2206286.","DOI":"10.1056\/NEJMoa2206286"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Tromp J, Ferreira JP, Janwanishstaporn S, Shah M, Greenberg B, Zannad F, et al. Heart failure around the world. <i>Eur J Heart Fail<\/i> 2019; 21: 1187\u20131196, doi:10.1002\/ejhf.1585.","DOI":"10.1002\/ejhf.1585"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Greene SJ, Butler J, Fonarow GC. Contextualizing risk among patients with heart failure. <i>JAMA<\/i> 2021; 326: 2261\u20132262, doi:10.1001\/jama.2021.20739.","DOI":"10.1001\/jama.2021.20739"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. Chioncel O, Mebazaa A, Harjola VP, Coats AJ, Piepoli MF, Crespo-Leiro MG, et al. Clinical phenotypes and outcome of patients hospitalized for acute heart failure: The ESC Heart Failure Long-Term Registry. <i>Eur J Heart Fail<\/i> 2017; 19: 1242\u20131254, doi:10.1002\/ejhf.890.","DOI":"10.1002\/ejhf.890"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24. Greene SJ, Fonarow GC, DeVore AD, Sharma PP, Vaduganathan M, Albert NM, et al. Titration of medical therapy for heart failure with reduced ejection fraction. <i>J Am Coll Cardiol<\/i> 2019; 73: 2365\u20132383, doi:10.1016\/j.jacc.2019.02.015.","DOI":"10.1016\/j.jacc.2019.02.015"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. Writing C, Maddox TM, Januzzi JL Jr, Allen LA, Breathett K, Butler J, et al. 2021 update to the 2017 ACC expert consensus decision pathway for optimization of heart failure treatment: Answers to 10 pivotal issues about heart failure with reduced ejection fraction: A report of the American College of Cardiology Solution Set Oversight Committee. <i>J Am Coll Cardiol<\/i> 2021; 77: 772\u2013810, doi:10.1016\/j.jacc.2020.11.022.","DOI":"10.1016\/j.jacc.2020.11.022"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/advpub\/0\/advpub_CJ-26-0697\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:33:22Z","timestamp":1790998402000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/advpub\/0\/advpub_CJ-26-0697\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,3]]},"references-count":25,"URL":"https:\/\/doi.org\/10.1253\/circj.cj-26-0697","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,3]]},"article-number":"CJ-26-0697"}}